| Name | Title | Contact Details |
|---|
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
POH Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. POH Medical Center is based in Pontiac, MI. You can find more information on POH Medical Center at www.pohmedical.org
Central California Blood Center is a Fresno, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Velcera is a Yardley, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Austin Radiological Association is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.